FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia

SIMPLE SUMMARY: FLT3-internal tandem duplication (ITD) mutation analysis in DNA samples is essential for optimal clinical management in patients with acute myeloid leukemia (AML). However, the utility of FLT3-ITD mutation analysis in cDNA samples and its use as a follow-up biomarker are controversia...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbonell, Diego, Chicano, María, Cardero, Alfonso J., Gómez-Centurión, Ignacio, Bailén, Rebeca, Oarbeascoa, Gillen, Martínez-Señarís, Diana, Franco, Carolina, Muñiz, Paula, Anguita, Javier, Kwon, Mi, Díez-Martín, José Luis, Buño, Ismael, Martínez-Laperche, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406666/
https://www.ncbi.nlm.nih.gov/pubmed/36010999
http://dx.doi.org/10.3390/cancers14164006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406666/
https://www.ncbi.nlm.nih.gov/pubmed/36010999
http://dx.doi.org/10.3390/cancers14164006

Ejemplares similares